AKT1 and neoplasm: Taken together, our results demonstrated that CD147 knockdown could suppress the tumor growth of melanoma by downregulating GLUT-1 via PI3K/Akt pathway, which could validate CD147 silencing by specific siRNAs as a new therapeutic regimen for treating melanoma.